Brief: Chimeric Therapeutics Seeks Trading Halt
22/03/2022 23:04
March 23 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* TRADING HALT
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PLACEMENT OF
SHORTFALL UNDER RETAIL ENTITLEMENT OFFER
Source text for Eikon: ID:nASX7MCZwP
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial